Excess coronary heart disease in Familial Combined Hyperlipidemia, in relation to genetic factors and central obesity

Atherosclerosis

Volumn 157, Issue 2, 2001, Pages 481-489

  Voors Pette, Christine ^a   De Bruin, Tjerk W A ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Coronary disease; Genetics; Lipids; Risk factors

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN C3; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALLELE; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; FAMILIAL HYPERLIPEMIA; FEMALE; GENE CLUSTER; GENETIC POLYMORPHISM; GLUCOSE BLOOD LEVEL; HEREDITY; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; LIFESPAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; RELATIVE; SPOUSE;

ADULT; ALLELES; APOLIPOPROTEIN A-I; APOLIPOPROTEIN C-III; APOLIPOPROTEINS A; APOLIPOPROTEINS C; BODY CONSTITUTION; CORONARY DISEASE; FEMALE; GENE FREQUENCY; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; MALE; MIDDLE AGED; MULTIGENE FAMILY; OBESITY; POLYMORPHISM, GENETIC; PREVALENCE; RISK FACTORS;

EID: 0034905682     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00752-8     Document Type: Article

References (48)

1. Myocardial infarction in the familial forms of hypertriglyceridemia
2. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia
3. Family study of serum lipids and lipoproteins in coronary heart-disease
4. Inheritance of combined hyperlipoproteinemia: Evidence for a new lipoprotein phenotype
5. Familial lipoprotein disorders in patients with premature coronary artery disease
6. Current concepts in genetics; the genetic hyperlipidemias
7. Phenotype expression in familial combined hyperlipidemia
8. Very low density lipoprotein overproduction in genetic forms of hypertriglyceridaemia
9. Low density lipoprotein metabolism in familial combined hyperlipidemia. Mechanism of the multiple lipoprotein phenotypic expression
10. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia
11. Inherited susceptibility determines the distribution of dense low-density lipoprotein subfraction profiles in familial combined hyperlipidemia
12. Metabolic and genetic aspects of familial combined hyperlipidaemia with emphasis on low-density lipoprotein heterogeneity
13. LDL physical and chemical properties in familial combined hyperlipidemia
14. Nonobese patients with familial combined hyperlipidemia are insulin resistant compared with their nonaffected relatives
15. Apolipoprotein, low density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia. Study of Utah patients with familial dyslipidemic hypertension
16. Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23
17. Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes
18. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: Effects on LDL-cholesterol and apolipoproteins B and C-III
19. Complex segregation analysis provides evidence for a major gene acting on serum triglyceride levels in 55 British families with familial combined hyperlipidemia
20. Segregation analysis of plasma apolipoprotein B levels in familial combined hyperlipidemia
21. Cardiovascular disease mortality in familial forms of hypertriglyceridemia: A 20-year prospective study
22. How good a marker is insulin level for insulin resistance?
23. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
24. Separation of plasma lipoproteins by density gradient ultracentrifugation
25. Families with Familial Combined Hyperlipidemia and families enriched for coronary artery disease share genetic determinants for the atherogenic lipoprotein phenotype
26. Nondenaturating polyacrylamide gradient gel electrophoresis
27. A simple salting out procedure for extracting DNA from human nucleated cells
28. Nonparametric estimation of incomplete observations
29. Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates
30. DNA restriction fragment length polymorphisms as markers of familial coronary heart disease
31. Genetic markers of familial coronary heart disease
32. DNA restriction polymorphisms of the apolipoprotein AI-CIII-AIV gene cluster: A genetic determinant of atherosclerosis in type 2 (non-insulin-dependent) diabetes mellitus
33. Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus
34. Lack of association between genetic variations of apo AI-CIII-AIV gene cluster and myocardial infarction in a sample of European mal: ECTIM study
35. Triglyceride-and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of Lovastatin
36. Interrelation between risk factors for cardiovascular disease in men aged 33-42. A study from Habo in Skaraborg County, Sweden
37. Central obesity and coronary heart disease in men
38. Waist/hip ratio, body mass index and premature cardiovascular disease mortality in US Army veterans during a twenty-three year follow-up study
39. Upper-body fat distribution: A hyperinsulinemia-independent predictor of coronary heart disease mortality. The Paris prospective study
40. Distribution of adipose tissue and risk of cardiovascular disease and death: A 12 year follow up of participants in the population study of women in Gothenburg, Sweden
41. Abdominal adiposity and coronary heart disease in women
42. 'Portal' adipose tissue as a generator of risk factors for cardiovascular disease and diabetes
43. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease
44. Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics
45. Fat distribution in European men: A comparison of anthropometric measurements in relation to cardiovascular risk factors
46. Adiposity, fat distribution, and cardiovascular risk